The feasibility and applications of non-invasive cardiac output monitoring, thromboelastography and transit-time flow measurement in living-related renal transplantation surgery: results of a prospective pilot observational study

Table 4 One year follow-up and outcome data for the studied group of ten living-related renal transplant recipients

Patient	DGF	Thromboembolic graft complication		VTE	Haemorrhagic graft complication		Rejection		Treatment for rejection	Creatinine 6 months	Creatinine 1 year	Dialysis (at 1 yr)
		Yes/No	Type		Yes/No	Type	Yes/No	Type
P1 ^a	✗	No		✗	Yes	Large perigraft haematoma	Yes	Early acute rejection.	^bATG for early rejection; successful	115	286	Yes
P1 ^a	✗	No		✗	Yes	Large perigraft haematoma	Yes	Chronic antibody mediated rejection from 9 months	^eCampath, no benefit	115	286	Yes
P2	✗	No		✗	No		No			120	111	No
P3	✗	Yes	Intra-operative transplant artery thrombosis - surgically corrected	✗	No		No			84	87	No
P4	✗	No		✗	No		No			67	79	No
P5	✓			✗			Yes	Antibody mediated acute rejection cause of ^cDGF	Early short term dialysis. ATG, Methylprednisolone, ^dMMF; successful	104	130	No
P6	✗	No		✗	No		Yes	Acute early rejection	ATG; successful	134	101	No
P7	✗	No		✗	No		Yes	Early antibody mediated rejection	Pulsed oral prednisolone regimen; successful	144	123	No
P8	✗	No		✗	No		No			129	129	No
P9	✗	No		✗	No		Yes	Early antibody mediated rejection	Pulsed oral prednisolone regimen; successful	103	114	No
P10	✗			✗	No		No				132	No

^aPatient (P) 1 demonstrated graft failure within 1-year as defined by a return to dialysis-dependent status. ^bATG, anti-thymocyte globulin; ^cDGF, delayed graft function; ^dMMF, mycophenolate mofetil; ^eCampath, Alemtuzumab.

ISSN: 2047-1440